Diluted HEPS from total operations of 11.4cps (-38.7% y-y).
Revenue from continuing ops down 2.6% y-y to R4 211m, attributed to lower private patient scripts as a result of the loss of the designated service provider contracts in Pharmacy Direct and the loss of margin in hospital products.
Expenses (excluding depreciation and amortisation) from continuing ops decreased 5.8% y-y, with expenses to sales down 200bps to 57.7%.
OPM from continuing ops improved from -1.3% to 4.5%.
No dividend.
Gross debt up from R628m to R654m. Net cash improved from R330m to R483m.
ACT disposed of its entire interest in AfroCentric Distribution Services (ADS), along with its wholly owned subsidiaries Tendahealth and AfroCentric Financial Services (AFS) to Sanlam Life for R2.8m. Medscheme disposed of its entire interest in Wellworx to Sanlam Life for R12.2m.
